Is nicotine polacrilex (a component of nicotine replacement therapy) an ingredient in nicotine patches for smoking cessation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Nicotine Polacrilex in Nicotine Patches?

No, nicotine polacrilex is not an ingredient in nicotine patches—it is the formulation used exclusively in nicotine gum. 1, 2

Understanding the Distinction

Nicotine replacement therapy products contain nicotine but deliver it through different pharmaceutical formulations:

  • Nicotine patches contain pure nicotine that is delivered transdermally (through the skin) over 16 or 24 hours, with doses of 21 mg, 14 mg, or 7 mg 1
  • Nicotine polacrilex is nicotine bound to an ion-exchange resin (polacrilex) that is released through chewing, available only in gum formulation at 2 mg or 4 mg doses 2, 3

Why the Formulations Differ

The polacrilex resin in gum serves a specific purpose that is irrelevant to patch delivery:

  • Polacrilex allows controlled release of nicotine through the buccal mucosa (mouth lining) during chewing, with approximately 53-72% of nicotine extracted from the gum depending on chewing technique 3
  • Patches deliver nicotine directly through skin absorption without requiring a resin carrier system 1
  • The pharmacokinetic profiles are fundamentally different: patches provide steady nicotine levels throughout the day, while gum provides faster but lower peak levels with each piece chewed 4, 5

Clinical Implications

Both products are equally effective for smoking cessation when used appropriately:

  • All four NRT products (gum, patch, nasal spray, inhaler) have similar success rates, with no controlled trial evidence favoring one product over another 6
  • The choice between patch and gum depends on practical and personal considerations rather than efficacy differences 6, 5
  • Combination therapy using both a patch and nicotine polacrilex gum together achieves superior outcomes (36.5% abstinence at 6 months) compared to either product alone (23.4% for patch monotherapy), nearly doubling cessation success 7, 8

References

Research

Determinants of nicotine intake while chewing nicotine polacrilex gum.

Clinical pharmacology and therapeutics, 1987

Research

Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2003

Guideline

Nicotine Replacement Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nicotine Addiction Treatment Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.